Inhibition of Phospholipase D1 Activity Improves the Recovery of Neurological Function in Mice with Ischemic Stroke

ObjectiveTo investigate the dynamic changes of autophagy in infarcted cortex at different stages after ischemic stroke, and the relationship between phospholipase D1 (PLD1) activity, autophagy, and the neurological function in mice.MethodsFirstly, twenty-one male C57BL/6 mice at age of 8 weeks were...

Full description

Bibliographic Details
Main Authors: ZHU Yanbing, BAI Fan, TAO Shaoxin, PAN Yuhualei, WANG Huan, ZHAO Yushang, WANG Song, YU Yan
Format: Article
Language:zho
Published: Editorial Office of Laboratory Animal and Comparative Medicine 2022-08-01
Series:Shiyan dongwu yu bijiao yixue
Subjects:
Online Access:https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2022.041
_version_ 1828097080356241408
author ZHU Yanbing
BAI Fan
TAO Shaoxin
PAN Yuhualei
WANG Huan
ZHAO Yushang
WANG Song
YU Yan
author_facet ZHU Yanbing
BAI Fan
TAO Shaoxin
PAN Yuhualei
WANG Huan
ZHAO Yushang
WANG Song
YU Yan
author_sort ZHU Yanbing
collection DOAJ
description ObjectiveTo investigate the dynamic changes of autophagy in infarcted cortex at different stages after ischemic stroke, and the relationship between phospholipase D1 (PLD1) activity, autophagy, and the neurological function in mice.MethodsFirstly, twenty-one male C57BL/6 mice at age of 8 weeks were used to establish ischemic stroke models, and they were randomly divided into sham surgery and ischemic stroke groups. The groups were furtherly divided into 4-, 6-, 8-, 12-, 24-, and 72-hour groups according to the onset of ischemic strok with three mice in each group. Dynamic expression and change of autophagy-related protein LC3 in the infarcted cortex were observed using Western blotting method and immunofluorescence staining. Secondly, thirty-six male C57BL/6 mice at age of 8 weeks were randomly divided into the sham surgery group, the PBS treatment group, and different concentrations of phospholipase D activity inhibitor 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) treatment groups containing 0.3, 0.9, 1.8, and 3.6 mg/kg, respectively. Each group comprised six mice. The optimal FIPI concentration and its effects on neurological function and infarcted volume were assessed by adhesive removal and whisker tests and TTC staining. Furthermore, nine male C57BL/6 mice at age of 8 weeks were divided into sham surgery group, intraperitoneal administration of PBS group, and 0.9 mg/kg FIPI group. Each group comprised three mice. The effects of FIPI on changes in autophagy-related protein LC3 were examined by Western blotting. Finally, thirty-six adult male C57BL/6 mice at age of 8 weeks were divided into sham surgery group, intraperitoneal administration of PBS group, and 0.9 mg/kg FIPI treatment groups at four time points (0, 4, 8, and 12 hours) after ischemic stroke. Furthermore, the neurological functions and infarcted volume were assessed by the adhesive removal and whisker tests as well as TTC staining with six mice in each group.ResultsThe ratio of LC3-Ⅱ/β-actin in the infarcted cortex increased, peaked at 24 hours (P<0.05), and then gradually declined after ischemic stroke. Compared with the PBS group, the administration of 0.9 mg/kg FIPI significantly decreased the ratio of LC3-Ⅱ/β-actin (P<0.05), reduced the infarcted area (P<0.05), and ameliorated neurological functions (P<0.05) more than those observed in the other concentration groups. Compared with the PBS group, in addition to 0.9 mg/kg FIPI without delay, the administration of 0.9 mg/kg FIPI at 4-, 8-, and 12-hour after ischemic stroke could also decrease the infracted volume (P<0.05) and improve the neurological function (P<0.05).ConclusionThe change of autophagy was the most obvious at 24-hour after ischemic stroke and inhibition of PLD1 could improve the recovery of neurological function after ischemic stroke. Meanwhile, in addition to administration of 0.9 mg/kg FIPI without delay, 4-, 8-, and 12-hour after ischemic stroke could also shrink the infracted volume and improve the neurological function. The inhibition of the PLD1 could extend the therapeutic window and provide a novel therapeutic strategy for the clinical treatment of cerebral stroke.
first_indexed 2024-04-11T07:41:24Z
format Article
id doaj.art-0b8aa7e8cddd443f971dcbc76c278805
institution Directory Open Access Journal
issn 1674-5817
language zho
last_indexed 2024-04-11T07:41:24Z
publishDate 2022-08-01
publisher Editorial Office of Laboratory Animal and Comparative Medicine
record_format Article
series Shiyan dongwu yu bijiao yixue
spelling doaj.art-0b8aa7e8cddd443f971dcbc76c2788052022-12-22T04:36:30ZzhoEditorial Office of Laboratory Animal and Comparative MedicineShiyan dongwu yu bijiao yixue1674-58172022-08-0142432233210.12300/j.issn.1674-5817.2022.0411674-5817(2022)04-0322-11Inhibition of Phospholipase D1 Activity Improves the Recovery of Neurological Function in Mice with Ischemic StrokeZHU Yanbing0BAI Fan1TAO Shaoxin2PAN Yuhualei3WANG Huan4ZHAO Yushang5WANG Song6YU Yan7Beijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaChina Rehabilitation Science Institute, China Rehabilitation Research Center, Beijing 100068, ChinaBeijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaBeijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaBeijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaBeijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaBeijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaChina Rehabilitation Science Institute, China Rehabilitation Research Center, Beijing 100068, ChinaObjectiveTo investigate the dynamic changes of autophagy in infarcted cortex at different stages after ischemic stroke, and the relationship between phospholipase D1 (PLD1) activity, autophagy, and the neurological function in mice.MethodsFirstly, twenty-one male C57BL/6 mice at age of 8 weeks were used to establish ischemic stroke models, and they were randomly divided into sham surgery and ischemic stroke groups. The groups were furtherly divided into 4-, 6-, 8-, 12-, 24-, and 72-hour groups according to the onset of ischemic strok with three mice in each group. Dynamic expression and change of autophagy-related protein LC3 in the infarcted cortex were observed using Western blotting method and immunofluorescence staining. Secondly, thirty-six male C57BL/6 mice at age of 8 weeks were randomly divided into the sham surgery group, the PBS treatment group, and different concentrations of phospholipase D activity inhibitor 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) treatment groups containing 0.3, 0.9, 1.8, and 3.6 mg/kg, respectively. Each group comprised six mice. The optimal FIPI concentration and its effects on neurological function and infarcted volume were assessed by adhesive removal and whisker tests and TTC staining. Furthermore, nine male C57BL/6 mice at age of 8 weeks were divided into sham surgery group, intraperitoneal administration of PBS group, and 0.9 mg/kg FIPI group. Each group comprised three mice. The effects of FIPI on changes in autophagy-related protein LC3 were examined by Western blotting. Finally, thirty-six adult male C57BL/6 mice at age of 8 weeks were divided into sham surgery group, intraperitoneal administration of PBS group, and 0.9 mg/kg FIPI treatment groups at four time points (0, 4, 8, and 12 hours) after ischemic stroke. Furthermore, the neurological functions and infarcted volume were assessed by the adhesive removal and whisker tests as well as TTC staining with six mice in each group.ResultsThe ratio of LC3-Ⅱ/β-actin in the infarcted cortex increased, peaked at 24 hours (P<0.05), and then gradually declined after ischemic stroke. Compared with the PBS group, the administration of 0.9 mg/kg FIPI significantly decreased the ratio of LC3-Ⅱ/β-actin (P<0.05), reduced the infarcted area (P<0.05), and ameliorated neurological functions (P<0.05) more than those observed in the other concentration groups. Compared with the PBS group, in addition to 0.9 mg/kg FIPI without delay, the administration of 0.9 mg/kg FIPI at 4-, 8-, and 12-hour after ischemic stroke could also decrease the infracted volume (P<0.05) and improve the neurological function (P<0.05).ConclusionThe change of autophagy was the most obvious at 24-hour after ischemic stroke and inhibition of PLD1 could improve the recovery of neurological function after ischemic stroke. Meanwhile, in addition to administration of 0.9 mg/kg FIPI without delay, 4-, 8-, and 12-hour after ischemic stroke could also shrink the infracted volume and improve the neurological function. The inhibition of the PLD1 could extend the therapeutic window and provide a novel therapeutic strategy for the clinical treatment of cerebral stroke.https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2022.041ischemic strokeautophagyphospholipase d1neurological functionc57bl/6 mice
spellingShingle ZHU Yanbing
BAI Fan
TAO Shaoxin
PAN Yuhualei
WANG Huan
ZHAO Yushang
WANG Song
YU Yan
Inhibition of Phospholipase D1 Activity Improves the Recovery of Neurological Function in Mice with Ischemic Stroke
Shiyan dongwu yu bijiao yixue
ischemic stroke
autophagy
phospholipase d1
neurological function
c57bl/6 mice
title Inhibition of Phospholipase D1 Activity Improves the Recovery of Neurological Function in Mice with Ischemic Stroke
title_full Inhibition of Phospholipase D1 Activity Improves the Recovery of Neurological Function in Mice with Ischemic Stroke
title_fullStr Inhibition of Phospholipase D1 Activity Improves the Recovery of Neurological Function in Mice with Ischemic Stroke
title_full_unstemmed Inhibition of Phospholipase D1 Activity Improves the Recovery of Neurological Function in Mice with Ischemic Stroke
title_short Inhibition of Phospholipase D1 Activity Improves the Recovery of Neurological Function in Mice with Ischemic Stroke
title_sort inhibition of phospholipase d1 activity improves the recovery of neurological function in mice with ischemic stroke
topic ischemic stroke
autophagy
phospholipase d1
neurological function
c57bl/6 mice
url https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2022.041
work_keys_str_mv AT zhuyanbing inhibitionofphospholipased1activityimprovestherecoveryofneurologicalfunctioninmicewithischemicstroke
AT baifan inhibitionofphospholipased1activityimprovestherecoveryofneurologicalfunctioninmicewithischemicstroke
AT taoshaoxin inhibitionofphospholipased1activityimprovestherecoveryofneurologicalfunctioninmicewithischemicstroke
AT panyuhualei inhibitionofphospholipased1activityimprovestherecoveryofneurologicalfunctioninmicewithischemicstroke
AT wanghuan inhibitionofphospholipased1activityimprovestherecoveryofneurologicalfunctioninmicewithischemicstroke
AT zhaoyushang inhibitionofphospholipased1activityimprovestherecoveryofneurologicalfunctioninmicewithischemicstroke
AT wangsong inhibitionofphospholipased1activityimprovestherecoveryofneurologicalfunctioninmicewithischemicstroke
AT yuyan inhibitionofphospholipased1activityimprovestherecoveryofneurologicalfunctioninmicewithischemicstroke